Cansativa Medical Devices GmbH has the mission to professionalize the whole devices and accessories industry around medical cannabis.
Dr. Markus Haller is chairman and founder of Cansativa Medical Devices GmbH. Dr. Haller has over 27 years of international experience, in large, medium and start-up companies and is a key innovative leader, with 55 patents filed, experienced in building creative organizations with the ability to deliver results. Dr. Haller developed three start-up companies from founding to sale (LMA Urology sold to Cook, Orthowin sold to Biomet, Sophono sold to Medtronic).
Dr. PD Christian Hauptmann is director of Cansativa Medical Devices GmbH. Dr. Hauptmann is an experienced neuroscientist and developer with over 20 years of International Experience, in several start- up companies and universities, with more then 48 patent filings and 55 scientific publications. Dr. Hauptmann developed several innovative neuromodulation techniques and transferred these into medical devices (invasive: implants and external trial device and non-invasive: visual, acoustic, vibro-tactile). Dr. Hauptmann is experienced in clinical testing and has vast experience in the management of IP portfolios.
Dipl. Ing. Alexander Wegener is director of Cansativa Medical Devices GmbH. Mr. Wegener is an very experienced engineer with more than 18 years background in invasive (retina implants, DBS implants) and non-invasive (visual, acoustic, vibro-tactile) technologies. With his MBA, quality and regulatory skills he is a key person for the structured development and approval of medical device products from idea to market entry. Mr. Wegener is experienced in setting up quality management systems and the regulatory approval of several medical devices (EU and US).
Cansativa Medical Devices GmbH
53474 Bad Neuenahr-Ahrweiler
|CEO:||Dr. Markus Haller|
|Registered Office:||Bad Neuenahr-Ahrweiler|
|Trade Register:||Frankfurt am Main HRB 115870|
|VAT ID No.:||DE815829849|